← back to search

Daniel Hilger

Ludwig-Maximilians-Universität München · DE
Area of research
Molecular Biology · Cellular and Molecular Neuroscience
Research interest
Research focused on G protein-coupled receptor and Heterotrimeric G protein, with related work in Receptor, G protein, Signal transduction. Notable publications include 'Structure of the µ-opioid receptor–Gi protein complex', 'Structural Insights into the Dynamic Process of β2-Adrenergic Receptor Signaling', and 'Yeast surface display platform for rapid discovery of conformationally selective nanobodies'.
h-index
citations
4,430
works
16
NIH funding
primary concept
email

Recent publications

GPR3 Ligands Discovered through Combined Virtual and Conformational Biosensor-Based Screening
Journal of the American Chemical Society 2025cited by 0position: middledoi
Time-resolved cryo-EM of G-protein activation by a GPCR
Nature 2024cited by 120position: middledoi
Cryo-EM structure of cell-free synthesized human histamine 2 receptor/Gs complex in nanodisc environment
Nature Communications 2024cited by 19position: middledoi
Cryo-EM structure of cell-free synthesized human histamine H <sub>2</sub> receptor coupled to heterotrimeric G <sub>s</sub> protein in lipid nanodisc environment
bioRxiv (Cold Spring Harbor Laboratory) 2023cited by 0position: middledoi
Structures of active melanocortin-4 receptor–Gs-protein complexes with NDP-α-MSH and setmelanotide
Cell Research 2021cited by 92position: middledoi
Viewing rare conformations of the β <sub>2</sub> adrenergic receptor with pressure-resolved DEER spectroscopy
Proceedings of the National Academy of Sciences 2020cited by 53position: middledoi
Structure of a Signaling Cannabinoid Receptor 1-G Protein Complex
Cell 2019cited by 445position: middledoi
Angiotensin Analogs with Divergent Bias Stabilize Distinct Receptor Conformations
Cell 2019cited by 290position: middledoi
Structure of the µ-opioid receptor–Gi protein complex
Nature 2018cited by 684position: middledoi
Yeast surface display platform for rapid discovery of conformationally selective nanobodies
Nature Structural & Molecular Biology 2018cited by 579position: middledoi
Development of an antibody fragment that stabilizes GPCR/G-protein complexes
Nature Communications 2018cited by 238position: middledoi
Structural mechanisms of selectivity and gating in anion channelrhodopsins
Nature 2018cited by 93position: middledoi
Single-molecule analysis of ligand efficacy in β2AR–G-protein activation
Nature 2017cited by 357position: middledoi
Structural Insights into the Dynamic Process of β2-Adrenergic Receptor Signaling
Cell 2015cited by 675position: middledoi
Structural basis for nucleotide exchange in heterotrimeric G proteins
Science 2015cited by 310position: middledoi
Structure of active β-arrestin-1 bound to a G-protein-coupled receptor phosphopeptide
Nature 2013cited by 475position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Brian K. Kobilka · Stanford University12 papers (2013–2024)Aashish Manglik · Chan Zuckerberg Initiative (United States)6 papers (2013–2018)Ron O. Dror · Stanford University5 papers (2015–2019)Georgios Skiniotis · Stanford Medicine4 papers (2018–2024)Wayne L. Hubbell · Doheny Eye Institute4 papers (2015–2020)Michael T. Lerch · Medical College of Wisconsin4 papers (2015–2020)Hannes Schihada · Philipps University of Marburg3 papers (2023–2025)Matthieu Masureel · Gene Therapy Laboratory3 papers (2015–2020)Shoji Maeda · University of Michigan–Ann Arbor3 papers (2018–2019)Peter Kolb · Philipps University of Marburg3 papers (2023–2025)Naomi R. Latorraca · University of California, Berkeley3 papers (2018–2019)William I. Weis · Stanford University3 papers (2013–2019)Hongli Hu · University of Michigan–Ann Arbor3 papers (2018–2019)Steffen Pockes · University of Regensburg3 papers (2023–2025) · 2 papers (2018–2019)Matthias Elgeti · Leipzig University2 papers (2019–2020)Joseph M. Paggi · Massachusetts Institute of Technology2 papers (2018–2018)Arne Møller · Aarhus University2 papers (2023–2024) · 2 papers (2023–2024) · 2 papers (2023–2024)